LaBrosse Nicole

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$2.22M

Insider Activity of LaBrosse Nicole

According to the SEC Form 4 filings, LaBrosse Nicole, being in a position of

  1. SVP, CHIEF FINANCIAL OFFICER at Halozyme Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 35000 shares for $1.83M,
    over all time since 2022-11-15, has bought 0 shares, and sold 42525 shares for $2.22M.

The largest sale of all time was on 2024-06-28 and amounted to 10000 shares of Halozyme Therapeutics, Inc. for $520,400.

Biography of LaBrosse Nicole

No biography is available at this moment.

2024-07-22SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
5,000
0.0039%
$53.93$269,662+1.58%
2024-06-28SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
10,000
0.0079%
$52.04$520,4000%
2024-06-27SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
10,000
0.0078%
$51.93$519,3400%
2024-06-26SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
10,000
0.0078%
$51.82$518,200+5.58%
2023-02-16SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
2,525
0.0019%
$49.26$124,382-24.84%
2022-11-15SaleHalozyme Therapeutics, Inc.
HALO
SVP, CHIEF FINANCIAL OFFICER
5,000
0.0036%
$53.81$269,053-27.07%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.